Alkermes to Become Third Drugmaker to Reinstitute Contract Pharmacy Restrictions in West Virginia and Kansas, Providers Condemn Move

A third drugmaker announced Monday that it would reinstate its contract pharmacy restrictions in Kansas and West Virginia effective March 3.
Ireland-based Alkermes announced this week that it will become the third drugmaker to reinstate contract pharmacy restrictions in Kansas and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS Communications Freeze Disrupts OPA, HRSA 340B Audits

340B covered entities reported continued disruptions days after the Trump Administration lifted its freeze on communications coming out of the Department of Health and Human Services (HHS).
340B covered entities this week reported continued disruptions in Office of Pharmacy Affairs (OPA) operations, as well as uncertainty around [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Condemn Sanofi’s Move to Reinstate Contract Pharmacy Restrictions in Kansas

Bryant Anderson, CEO of PrairieStar Health Center in Hutchinson, Kan., criticized Sanofi's decision to reinstate its contract pharmacy restrictions in the state.
A France-based drugmaker recently reinstated its contract pharmacy restrictions in Kansas following a successful challenge of the state’s contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Connecticut Bill Would Make Medicaid Reimbursement Contingent on 340B Reporting Requirements

A bill introduced last week would require 340B covered entities in Connecticut to report how they use program savings or risk losing their Medicaid reimbursement .
A newly introduced Connecticut bill would require 340B covered entities to report how they use program savings as a condition [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

White House Rescinds Funding Freeze, But Concern Among Health Centers Remain 

President Donald Trump (R) addressed the media Wednesday after rescinding a memo to freeze trillions of dollars of federal funds.
The White House this week issued and then quickly rescinded a policy that froze trillions in federal funding following multiple [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA-backed Conservative Think Tank Suggests DOGE Should Prioritize 340B Reform to Cut Government Costs

ALEC, a drug industry-funded conservative policy group, suggested 340B reform “is a great place to start” in improving government efficiency.
A drug industry-funded conservative policy group suggested that 340B reform “should be a priority” for large scale government cost-cutting efforts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Hospital Sues HRSA Over 340B Removal, Seeks Retroactive Eligibility

A California-based hospital sued HRSA in the U.S. District Court for the District of Columbia, alleging the agency "unlawfully" prevented the hospital from accessing the 340B program for six months.
A California-based hospital has sued the Health Resources and Services Administration (HRSA), alleging the agency unlawfully prevented it from accessing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Connecticut Lawmaker Introduces 340B Cost Reporting Bill, Providers Warn of ‘Unnecessary Burden’

A Connecticut lawmaker introduced a bill this week that would require hospitals, pharmacies, PBMs and insurers to report how much they charge patients for 340B drugs.
Connecticut hospitals, pharmacy benefit managers (PBMs), pharmacies and insurance companies would have to report how much they charge patients for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

NYT Investigation Highlights Federal Law’s Unintended Harm to 340B Providers

A recent New York Times investigation found that part of a COVID-19 relief bill meant to lower drug prices actually increased costs for 340B providers and some of their most vulnerable patients.
A provision in a 2021 COVID-19 relief bill that sought to lower prescription drug prices has actually made some medications [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Just Before Departing, Biden Admin Announces Next 15 Drugs for Medicare Negotiations Amid IRA Uncertainty and 340B Questions

The second group of high-cost prescription drugs chosen for Medicare price negotiations were announced last week just ahead of former President Joe Biden's departure from the White House.
The Department of Health and Human Services (HHS) announced the second group of high-cost prescription drugs chosen for Medicare price [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live